MAPT and Alzheimer disease: The temporal ordering of p-tau abnormality [12, 15–17], as well as their preferential association with amyloid-β plaques and tau neurofibrillary tangles [18, 19], suggests that assessing multiple p-tau species may be useful for tracking disease severity in AD [20, 21].